Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Completed 11Recruiting 7Not yet recruiting 4Active not recruiting 4Unknown 3Terminated 2Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 11Gastrointestinal 7Tumor-Agnostic 4Genitourinary 3Thoracic 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Head & Neck 1Endocrine 1

Conditions

Neoplasm Metastasis 3Neoplasms 1

Interventions

Standard of Care 4Radiotherapy 4Oxaliplatin 4tislelizumab 3trastuzumab deruxtecan 2pembrolizumab 2cemiplimab 2anlotinib 2Radiation 2Paclitaxel 2Capecitabine 2130-nm albumin-bound paclitaxel 2vedolizumab 1trametinib 1toripalimab 1surufatinib 1ivosidenib 1disitamab vedotin 1coenzyme Q10 1blinatumomab 1Whole Genome Sequencing 1Ursodeoxycholic Acid 1Ultrasonography 1Tretinoin 1Thymopentin 1Surgical Procedures, Operative 1Sequence Analysis, RNA 1Respiratory Rate 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Standard of Care × Tumor-Agnostic × Clear all
NCT07550478 2026-04-24

Impact of Pharmacist-Led Intervention on Adult Oncology Outpatients

Badr University

Phase NA Not yet recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT07540650 2026-04-20

pRevenT

Institute of Oncology Ljubljana

Phase 2 Not yet recruiting
90 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT07346209 2026-04-08

STRIPe

University of California, San Diego

Phase 2 Not yet recruiting
280 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06961188 2025-05-07

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
174 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡